Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CannaKorp was a Massachusetts-based private cannabis technology company that developed a pod-based vaporization platform for medical cannabis and other botanical products. Its core offering was the Wisp system, which combined a vaporizer device with single-use, precisely measured pods and a proprietary pod-filling process intended to improve dosing consistency, convenience, and product quality. The company positioned its technology as a standardized inhalation platform for medical, wellness, and adult-use cannabis markets. CannaKorp was acquired by Target Group effective March 1, 2019, and continued as a subsidiary after the transaction. More recent business-directory sources indicate the standalone company is now closed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CannaKorp.